Revolution Medicines (NasdaqGS:RVMD) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Company ParticipantsRyan Asay - SVP of Corporate AffairsWei Lin - CMOAlan Sandler - Chief Development OfficerSteve Kelsey - President of Research and DevelopmentAlec Stranahan - Biotechnology Equity ResearchMark Goldsmith - Chairman and CEOJenna Li - Biotech Equity Research Senior AssociateAnthony Mancini - Chief Global Commercialization OfficerConference Call ParticipantsJoseph Catanzaro - Senior Biotech Equity Analyst ...

Revolution Medicines (NasdaqGS:RVMD) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Company ParticipantsRyan Asay - SVP of Corporate AffairsWei Lin - CMOAlan Sandler - Chief Development OfficerSteve Kelsey - President of Research and DevelopmentAlec Stranahan - Biotechnology Equity ResearchMark Goldsmith - Chairman and CEOJenna Li - Biotech Equity Research Senior AssociateAnthony Mancini - Chief Global Commercialization OfficerConference Call ParticipantsJoseph Catanzaro - Senior Biotech Equity Analyst ...

Revolution Medicines (NasdaqGS:RVMD) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker0Good day, and thank you for standing by. Welcome to the Revolution Medicines Q3 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press Star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdr ...